121 related articles for article (PubMed ID: 36437036)
1. Comparing algorithms for characterizing treatment effect heterogeneity in randomized trials.
Sun S; Sechidis K; Chen Y; Lu J; Ma C; Mirshani A; Ohlssen D; Vandemeulebroecke M; Bornkamp B
Biom J; 2024 Jan; 66(1):e2100337. PubMed ID: 36437036
[TBL] [Abstract][Full Text] [Related]
2. Comparison of methods that combine multiple randomized trials to estimate heterogeneous treatment effects.
Brantner CL; Nguyen TQ; Tang T; Zhao C; Hong H; Stuart EA
Stat Med; 2024 Mar; 43(7):1291-1314. PubMed ID: 38273647
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Causal rule ensemble method for estimating heterogeneous treatment effect with consideration of prognostic effects.
Hiraishi M; Wan K; Tanioka K; Yadohisa H; Shimokawa T
Stat Methods Med Res; 2024 Jun; 33(6):1021-1042. PubMed ID: 38676367
[TBL] [Abstract][Full Text] [Related]
5. A new method for clustered survival data: Estimation of treatment effect heterogeneity and variable selection.
Hu L
Biom J; 2024 Jan; 66(1):e2200178. PubMed ID: 38072661
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. Subgroup identification in dose-finding trials via model-based recursive partitioning.
Thomas M; Bornkamp B; Seibold H
Stat Med; 2018 May; 37(10):1608-1624. PubMed ID: 29388228
[TBL] [Abstract][Full Text] [Related]
8. Emulate randomized clinical trials using heterogeneous treatment effect estimation for personalized treatments: Methodology review and benchmark.
Ling Y; Upadhyaya P; Chen L; Jiang X; Kim Y
J Biomed Inform; 2023 Jan; 137():104256. PubMed ID: 36455806
[TBL] [Abstract][Full Text] [Related]
9. Assessing the properties of patient-specific treatment effect estimates from causal forest algorithms under essential heterogeneity.
Brooks JM; Chapman CG; Chen BK; Floyd SB; Hikmet N
BMC Med Res Methodol; 2024 Mar; 24(1):66. PubMed ID: 38481139
[TBL] [Abstract][Full Text] [Related]
10. Sample size estimation for cancer randomized trials in the presence of heterogeneous populations.
Dinart D; Bellera C; Rondeau V
Biometrics; 2022 Dec; 78(4):1662-1673. PubMed ID: 34242412
[TBL] [Abstract][Full Text] [Related]
11. Treatment evaluation for a data-driven subgroup in adaptive enrichment designs of clinical trials.
Zhang Z; Chen R; Soon G; Zhang H
Stat Med; 2018 Jan; 37(1):1-11. PubMed ID: 28948633
[TBL] [Abstract][Full Text] [Related]
12. Quint: An R package for the identification of subgroups of clients who differ in which treatment alternative is best for them.
Dusseldorp E; Doove L; Mechelen Iv
Behav Res Methods; 2016 Jun; 48(2):650-63. PubMed ID: 26092391
[TBL] [Abstract][Full Text] [Related]
13. AIPW: An R Package for Augmented Inverse Probability-Weighted Estimation of Average Causal Effects.
Zhong Y; Kennedy EH; Bodnar LM; Naimi AI
Am J Epidemiol; 2021 Dec; 190(12):2690-2699. PubMed ID: 34268567
[TBL] [Abstract][Full Text] [Related]
14. A permutation procedure to detect heterogeneous treatment effects in randomized clinical trials while controlling the type I error rate.
Wolf JM; Koopmeiners JS; Vock DM
Clin Trials; 2022 Oct; 19(5):512-521. PubMed ID: 35531765
[TBL] [Abstract][Full Text] [Related]
15. Estimation of treatment effects in all-comers randomized clinical trials with a predictive marker.
Choai Y; Matsui S
Biometrics; 2015 Mar; 71(1):25-32. PubMed ID: 25303178
[TBL] [Abstract][Full Text] [Related]
16. Subpopulation Treatment Effect Pattern Plot (STEPP) analysis for continuous, binary, and count outcomes.
Yip WK; Bonetti M; Cole BF; Barcella W; Wang XV; Lazar A; Gelber RD
Clin Trials; 2016 Aug; 13(4):382-90. PubMed ID: 27094489
[TBL] [Abstract][Full Text] [Related]
17. Statistical approaches to identify subgroups in meta-analysis of individual participant data: a simulation study.
Belias M; Rovers MM; Reitsma JB; Debray TPA; IntHout J
BMC Med Res Methodol; 2019 Sep; 19(1):183. PubMed ID: 31477023
[TBL] [Abstract][Full Text] [Related]
18. Comparison of machine learning clustering algorithms for detecting heterogeneity of treatment effect in acute respiratory distress syndrome: A secondary analysis of three randomised controlled trials.
Sinha P; Spicer A; Delucchi KL; McAuley DF; Calfee CS; Churpek MM
EBioMedicine; 2021 Dec; 74():103697. PubMed ID: 34861492
[TBL] [Abstract][Full Text] [Related]
19. Comparing analytical strategies for balancing site-level characteristics in stepped-wedge cluster randomized trials: a simulation study.
Ma C; Lee A; Courtney D; Castle D; Wang W
BMC Med Res Methodol; 2023 Sep; 23(1):206. PubMed ID: 37700232
[TBL] [Abstract][Full Text] [Related]
20. Subgroup-specific dose finding for phase I-II trials using Bayesian clustering.
Curtis A; Smith B; Chapple AG
Stat Med; 2022 Jul; 41(16):3164-3179. PubMed ID: 35429178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
